Key result
Aldosterone induced ELT-3 leiomyoma cell proliferation, which was effectively repressed by pre-incubating the cells with the mineralocorticoid receptor blockers spironolactone or eplerenone.
Why the study?
Does aldosterone stimulate proliferation in ELT-3 leiomyoma cells?
Does aldosterone stimulate proliferation in ELT-3 leiomyoma cells?
Aldosterone stimulates uterine leiomyoma cell proliferation in vitro, providing a potential mechanistic link between elevated blood pressure and leiomyoma risk.
No takes yet. Share an insight, caveat, or question.
May link aldosterone to leiomyoma risk beyond BP; hypothesis-generating and should not yet change practice.
Isobe et al. (2010) studied Uterine leiomyomas. Aldosterone vs. Mineralocorticoid receptor blockers (spironolactone or eplerenone) was evaluated on ELT-3 leiomyoma cell proliferation. Aldosterone induced ELT-3 leiomyoma cell proliferation, which was effectively repressed by pre-incubating the cells with the mineralocorticoid receptor blockers spironolactone or eplerenone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: